Rising Rate of Births Among High Risk Women Driving the NIPT Market

‘The trend of increased high risk pregnancies has been driving the US NIPT market which will grow at a CAGR of over 20% for the next 5 years’, says RNCOS.

 

Noida, UP -- (ReleaseWire) -- 07/07/2014 -- Women nowadays are deferring the child bearing age to late 30s and 40s especially in the US. The demography of motherhood in the United States has shifted strikingly in the past two decades. Compared with mothers of newborns in 1990, today’s mothers of newborns are older and better educated.

This trend has been attributed to numerous factors such as recession and associated affordability issues and women being more career focused than before. However, with an increase in the age of the woman, the risk of chromosomal abnormalities such as Down’s Syndrome also increases. Such a rise in the childbearing age has been contributing to the growth of the NIPT market which is anticipated to grow at a CAGR of over 20% for the next 5 year.

Our latest research report “US Non-Invasive Prenatal Testing Market Outlook 2018”, provides a prudent analysis on the current and future size of the market weighing the possible pessimistic and optimistic scenarios. In addition to it, the report has even mentioned the potential market for high and medium to high risk pregnancy patients. The demographic scenario of United States has been discussed with focus on the current and future number of births, with the demographics segregated by age and state.

It also provides a transparent view on the present regulatory framework elaborating on the existing loopholes. Our report has discussed the views of regulatory authorities, players and consumers towards the regulatory stringency and the direction of regulations in the future have also been covered.

Currently, the US NIPT sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These players have been profiled with their strengths and weaknesses and latest developments in the field of NIPT. The report is a must buy for new market entrants in the diagnostics field, planning to enter the prenatal segment.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM668.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.